Key result
Synthetic ANP increases plasma renin activity both pre- and postdialysis in hemodialysis patients.
Why the study?
Does synthetic atrial natriuretic peptide alter hemodynamic and hormonal responses in anuric subjects on regular hemodialysis?
Does synthetic atrial natriuretic peptide alter hemodynamic and hormonal responses in anuric subjects on regular hemodialysis?
In anuric hemodialysis patients, synthetic ANP reduces blood pressure and directly decreases plasma aldosterone and cortisol while reflexively activating the sympathetic nervous system.
Answers are grounded in this paper and cite their sources.
ANP may reflexively activate renin in anuric hemodialysis; leaves open net hormonal impact on volume control.
The effects of atrial natriuretic peptide (ANP) on mean arterial blood pressure, heart rate, plasma renin activity, aldosterone, cortisol, norepinephrine, epinephrine and arginine vasopressin were studied in 6 anuric subjects receiving regular hemodialysis. An iv bolus injection of 8 nmol of ANP followed by infusion at 32 pmol.kg-1.min-1 for 1 h in the pre- and posthemodialysis period was performed. Basal plasma ANP was higher before than after hemodialysis. ANP administration produced a reduction in mean arterial blood pressure accompanied by an elevation of norepinephrine and of plasma renin activity (from 2.49 +/- 0.52 to 3.39 +/- 0.85 nmol.1-1.h-1 predialysis and from 2.78 +/- 0.71 to 3.15 +/- 0.86 nmol.l-1.h-1 postdialysis, respectively, mean +/- SEM; P less than 0.05). Plasma aldosterone and cortisol were significantly decreased. Plasma epinephrine and AVP remained unchanged. These hemodynamic and hormonal changes were similar in the pre- and the postdialysis period. These results suggest that 1) ANP causes a fall in mean arterial blood pressure, which in turn induces reflex tachycardia and activation of the sympathetic nervous system without diuresis; 2) the activated sympathetic nervous system as reflected in elevation of plasma norepinephrine may increase plasma renin activity; 3) reduced plasma aldosterone is not influenced by enhancement of the renin-angiotensin system; therefore, 4) reduction of plasma aldosterone as well as cortisol is probably due to direct action of ANP, and finally 5) AVP had no direct relation with ANP administration.
No takes yet. Share an insight, caveat, or question.
Nakajima et al. (1988) studied anuric subjects receiving regular hemodialysis (n=6). synthetic atrial natriuretic peptide (ANP) vs. Basal levels was evaluated on plasma renin activity (p=<0.05). Synthetic atrial natriuretic peptide increased plasma renin activity from 2.49 to 3.39 nmol/L/h predialysis and from 2.78 to 3.15 nmol/L/h postdialysis in hemodialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: